Inclusion Criteria:
  -  Women with digital breast tomosynthesis and/or ultrasound assessments of Breast Imaging Reporting and Data System (BI-RADS) 4 and 5 lesions with recommendation of needle biopsy for tissue diagnosis.
  -  Abnormal findings include masses, focal, global or developing asymmetries, architecture distortions, or > 1 cm of suspicious calcifications with or without associated ultrasound abnormal findings.
  -  Scheduled for imaging guided percutaneous needle biopsy.
  -  Provide signed and dated informed consent form.
  -  If patient is of childbearing potential, a negative pregnancy test, urine or blood, within 14 days prior to the scan.
Exclusion Criteria:
  -  < 1 cm span of calcifications without an ultrasound correlate.
  -  Pregnant patients.
  -  Patients with a glomerular filtration rate (GFR) < 30 mL/min/1.73 m^2 (based on lab results within 30 days prior to exam) or with chronic kidney disease on hemodialysis.
  -  Patients with known allergy to iodinated contrast material.